Category: Workers Comp

558 posts found

Marijuana Laws No Longer Thought to Reduce Opioid Overdose Deaths

A new study builds upon earlier research with a larger, more up-to-date dataset, finding a reversal in trends.

Healthesystems at WCI Orlando 2019

Visit Healthesystems in booth #909 and learn how we’re making waves in workers’ comp, and how we hope to benefit coastal cleanups for the “Coast to Coast” theme.

Medmonitor

FDA Reexamines Discontinued Drug for New Pain Applications

Orphengesic Forte has received a decision date of August 14, 2019.

This Month's Must Read

Shifting Gears in Patient Transportation with Rideshare

How services like Lyft and Uber can amplify injured worker transportation programs to improve claims outcomes.

Clinical Insights

The Growing Utilization and Costs of Anticancer Medications

Though they’re only needed for special cases in workers’ comp, anticancer medications can easily exceed $10,000 per monthly fill.

Opioid Developments

FDA Proposes Fixed-Quantity Blister Packaging for Certain Opioids

In a call for public comment, the FDA believes that reducing excess opioid supplies can lower opioid misuse, abuse, and overdose.

Medmonitor

FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose

The life saving antidote for opioid overdose will soon be available in a consumer-friendly, generic nasal spray.

This Month's Must Read

2019 Workers’ Comp Industry Insights Survey

Healthesystems partnered with Risk & Insurance magazine to survey 500+ work comp professionals on their top challenges, trends, successes, and more.

Clinical Insights

Negative Impacts of Combining Antidepressants with Opioids and Benzodiazepines

Combining all three drugs can reduce claim closure rates to 58.3%, with average claim costs of $94,000.

Legislation & Policy

Growing Trend: Expanding Cancer Coverage for Firefighters

Florida enacted a law to cover 21 different cancers, while other states like Montana, Maryland, and Virginia have recently passed similar laws.

Opioid Developments

National Institute of Health to Launch $350 Million Opioid Intervention Study

Four research sites will test proven opioid prevention and treatment interventions, hoping to reduce overdose deaths by 40% over three years.

Medmonitor

FDA Tightens Restrictions for Transmucosal Fentanyl Products

New changes to REMS safety programs will require stronger treatment documentation and oversight.

This Month's Must Read

Patient Engagement is Personal: How to Help Injured Workers Help Themselves

Patient engagement can lead to better health outcomes, but not all engagement strategies are equally effective.

Clinical Insights

The Impact of the Changing Workforce

The workforce is aging, getting younger, and gaining more women, all at once. What does that mean for claims management?

Legislation & Policy

Marijuana Continues to Take Major Steps Forward

Congress may soon clear federal restrictions to processing marijuana transactions, while the FDA asks for feedback on handling marijuana products.

Prev 1 2 3 4 5 … 30 31 32 33 34 35 36 37 38 Next